Article 47 of the EU AI Act requires that for each high-risk AI system, the provider draws up an EU Declaration of Conformity in accordance with Annex V before placing the system on the market or putting it into service. By drawing up the declaration, the provider declares that the high-risk AI system meets the requirements of the AI Act.
The Declaration of Conformity is the single document that translates the entire conformity-assessment procedure into a public, signed statement. It is the formal counterpart to the CE marking: CE marks the system physically, the Declaration declares the compliance in writing.
Format requirement: Per Art 47(3), the declaration must be drawn up in the official EU language(s) determined by the Member State in which the system is placed on the market. DEFONEOS provides a 23-language-ready template (English plus the 22 other EU official languages). The Declaration must be kept by the provider for 10 years after placement on the market (Art 47(4)).
In accordance with Regulation (EU) 2024/1689 of the European Parliament and of the Council (Artificial Intelligence Act), Article 47, and Annex V
This declaration of conformity is the formal attestation that DEFONEOS meets all applicable requirements of Regulation (EU) 2024/1689 as of the date of issue. Any material change to the AI system or its intended purpose requires re-issuance under Article 49(3).
For high-risk systems under Annex III (e.g., recruitment AI, credit-scoring AI, education assessment AI) that are NOT also under Annex I Section A. The provider performs internal conformity assessment and signs the declaration. Field 5 marked "Not applicable — Module A self-assessment".
For biometric AI, critical-infrastructure AI, or safety-component AI under Annex I Section A. The notified body is named in Field 5, and the certificate reference is recorded. The provider still signs the declaration (responsibility remains with the provider), but the conformity assessment itself was third-party.
Per Art 47(3), the Declaration must be available in the official language(s) of the Member State where the system is placed on the market. DEFONEOS provides:
Cost consideration: 22 official-language translations × ~2,000 words = ~44,000 words. EU-certified technical translators charge ~€0.10-0.20/word → ~€4,400-8,800 per full set. DEFONEOS phases this: EN first, then top 5 (FR/DE/ES/IT/PL), then full 23 before EU market placement.
| Trigger | Action | Art Reference |
|---|---|---|
| System version bump (major) | Re-issue declaration, mark as revision 2.x | Art 49(3) substantial modification |
| Risk class change | Re-assess conformity module, re-issue | Art 49(3) |
| New jurisdiction (Member State) | Translate to that state's language | Art 47(3) |
| Harmonised standard update | Verify continued compliance, update Field 4 | Art 47(1) |
| Notified-body certificate expiry | Renew assessment, update Field 5 | Art 43(2) |
| 10-year retention expiry | Archive (do not destroy — for regulator queries) | Art 47(4) |
| Framework | Equivalent Provision | DEFONEOS Mapping |
|---|---|---|
| EU AI Act Art 47 | EU Declaration of Conformity | This page |
| EU AI Act Annex V | Declaration content template | 7-field structure above |
| Decision 768/2008 Annex III | General Declaration template | Adapted to AI Act |
| Regulation 765/2008 Art 5 | Declaration as legal effect | Field 3 |
| UK UKCA Declaration | UK post-Brexit equivalent | Documented but not used in EU |
| EU Machinery Regulation 2023/1230 | Declaration for AI safety components | Where AI is a machinery safety component |
| EU Medical Device Reg 2017/745 | Declaration for AI medical devices | Where AI is a medical device |
| ISO/IEC 17050 | Supplier's Declaration of Conformity (general) | Form basis |
| NIST AI RMF | Trustworthy characteristics declaration | Aligned with Field 4 |
| C2PA 2.0 | Provenance attestation | Field 7 SIGIL anchor |
1. The Declaration above is a TEMPLATE — it has NOT been issued for a live DEFONEOS deployment. Live issuance requires (a) CSOAI Ltd's registered office address to be finalised, (b) Module A or notified-body conformity assessment to be completed, and (c) all 8 preconditions from the CE marking page to be formally MET.
2. The signature line is illustrative — no live declaration has been signed. The Ed25519 signature slot is structurally defined but contains a placeholder until issuance.
3. Field 1 (intended purpose) reflects DEFONEOS positioning but is general — live deployments specify the precise public service function, jurisdiction, and decision categories per Art 13(3)(a).
4. For Annex I Section A deployments (biometric AI, critical infrastructure), the notified-body route applies — DEFONEOS anticipates requiring this for biometric identity verification in public services and certain counter-drone deployments.
5. Harmonised standards in Field 4 are those DEFONEOS aligns with, but only standards that have been published as "harmonised" under the AI Act (via the European Standardisation Organisations — CEN/CENELEC/ETSI) carry the formal presumption of conformity. The list will be updated as the AI Office publishes the harmonised-standards list.
6. 23-language translation requires regulatory-grade translators; machine translation alone is insufficient for legal documents. DEFONEOS phases translation by market entry priority.
7. Authorised representative per Art 22 is required where the provider is not established in the EU. CSOAI Ltd is UK-based, so for EU market placement an AR is required. The AR slot is structurally defined but empty pending AR appointment.
Every Declaration issuance, revision, and translation triggers a SIGIL event of type P (Publication) with the declaration_id, schema_version, language code, and Ed25519 signature. The SIGIL chain provides an immutable public record of every Declaration ever issued by DEFONEOS.
Public SIGIL explorer: https://csoai.org/v1/sigil/events?actor=defoneos&action=eu-declaration
7 personas · 5 tiers · 30-second signup · free 30-day sandbox for regulators and end-users.
Sign up · Ed25519-signed receipt → For Defence Primes For Regulators (Free) Series A — £45-90M Round